000 01358 a2200409 4500
005 20250515021539.0
264 0 _c20060928
008 200609s 0 0 eng d
022 _a0950-9232
024 7 _a10.1038/sj.onc.1209521
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKeren-Paz, A
245 0 0 _aOverexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions.
_h[electronic resource]
260 _bOncogene
_cAug 2006
300 _a5163-72 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a3T3 Cells
650 0 4 _aAnimals
650 0 4 _aBase Sequence
650 0 4 _aCell Division
_xphysiology
650 0 4 _aCell Line
650 0 4 _aCell Transformation, Neoplastic
650 0 4 _aDNA Primers
650 0 4 _aFibroblasts
_xcytology
650 0 4 _aMice
650 0 4 _aOrnithine Decarboxylase
_xgenetics
650 0 4 _aProteins
_xgenetics
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTransfection
700 1 _aBercovich, Z
700 1 _aPorat, Z
700 1 _aErez, O
700 1 _aBrener, O
700 1 _aKahana, C
773 0 _tOncogene
_gvol. 25
_gno. 37
_gp. 5163-72
856 4 0 _uhttps://doi.org/10.1038/sj.onc.1209521
_zAvailable from publisher's website
999 _c16175359
_d16175359